Physician profile
Young Kang
NPI 1720050529
$3,797.41
in general payments reported to CMS, 2019-2025
19 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $78.40 · 2021: $27.17 · 2022: $517 · 2023: $511 · 2024: $2,206 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $2,016 · Food and Beverage: $444 · Travel and Lodging: $262 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $2,015.53 |
| Food and Beverage | $443.81 |
| Travel and Lodging | $262.16 |
| Education | $116.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $2,367.30 | 2022-2024 | Oes Cystonephrofiberscope |
| Procept Biorobotics Corporation | $340.16 | 2023 | Aquabeam Robotic System |
| Astellas Pharma US INC | $254.29 | 2019-2024 | Xtandi |
| Boston Scientific Corporation | $192.51 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $120.04 | 2023-2025 | Gemtesa |
| Immunitybio, INC. | $117.17 | 2024 | |
| Janssen Biotech, INC. | $91.54 | 2019-2025 | Rybrevant, Carvykti |
| Dornier Medtech America, INC | $61.29 | 2022 | |
| Axonics, INC. | $45.37 | 2022-2023 | Bulkamid |
| Abbvie INC. | $40.48 | 2020-2021 | |
| Teleflex LLC | $23.46 | 2025 | Barrigel |
| Bayer Healthcare Pharmaceuticals INC. | $23.18 | 2019 | |
| Pfizer INC. | $22.02 | 2024 | |
| Dendreon Pharmaceuticals LLC | $20.23 | 2019 | |
| Endo Pharmaceuticals INC. | $16.60 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $16.26 | 2024 | |
| Myriad Genetic Laboratories, INC. | $15.58 | 2022 | |
| Rochester Medical Corporation | $15.17 | 2021 | |
| Accord Healthcare, INC. | $14.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Young Kang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.